applying for approval
Scope
Date
~
-
Artificial intelligence
S.Korean IT firms rush for tie-ups to compete with ChatGPT
South Korean tech companies are rushing to form partnerships in different sectors to develop superior AI services to compete with ChatGPT, a chatbot...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom develops reconfigurable surface tech for 6G transmission
SK Telecom Co. on Thursday said it developed the world's first reconfigurable intelligent surface (RIS) technology that transmits 6G candidate frequ...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved by Chilean health authority
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, announced on Thursday that its world-first cell culture-based quadr...
Feb 02, 2023 (Gmt+09:00)
-
Banking & Finance
Korea's credit card approval volume hit all-time high last year
The annual card approval amount in South Korea exceeded 1,000 trillion won ($811.4 billion) for the first time ever. This is largely because of "ret...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Nibec gets approval for its bone graft biomaterials in Colombia, Mexico
South Korea's bioactive peptide technology company Nibec Co. said on Friday that it has obtained product approval for the sale of two types of denta...
Jan 27, 2023 (Gmt+09:00)
-
Batteries
POSCO gets nod for battery technology transfer to overseas plants
POSCO Chemical Co., a unit of South Korean steelmaker POSCO Holdings Co., on Thursday won government approval to transfer technology to its overseas...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota wins approval from Australia
Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Ja...
Jan 26, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Take QR code instead of long password when connecting to Wi-Fi
LG Uplus Corp. introduced a functionality that allows access to Wi-Fi through an Internet TV screen. This is intended to make it possible to connect...
Jan 25, 2023 (Gmt+09:00)
-
Shareholder activism
K-pop label SM taps activist investor as board member
K-pop behemoth SM Entertainment Co. said on Jan. 20 it has decided to tap Lee Chang-hwan, the CEO of local activist fund Align Partners Capital Mana...
Jan 20, 2023 (Gmt+09:00)
-
Energy
Doosan Enerbility acquires US design approval for metal nuclear cask
South Korea's energy equipment maker Doosan Enerbility Co. has obtained the green light in participating in the domestic nuclear storage cask market...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Sanfilippo treatment eligible for FDA priority review
GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Biomedics gets approval for Parkinson's disease clinical trials
South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...
Jan 13, 2023 (Gmt+09:00)
-
Chemical Industry
KCC to mass produce ceramics for eco-friendly vacuum interrupters
KCC Corp. said on Thursday that it would mass produce ceramic products for eco-friendly vacuum interrupters that do not emit sulfur hexafluoride (SF...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N gets approval to sell K-CAB in Singapore
South Korean biohealth company HK inno.N said on Wednesday that it has received an item approval for K-CAB, a new drug for gastroesophageal reflux d...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's shingles vaccine obtains product approval from Malaysia
SK Bioscience Co. said on Monday that its shingles vaccine Sky Zoster has been given approval by Malaysia's National Pharmaceutical Regulatory Age...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Plasmapp, Curexo agree on joint development of surgical robot solutions
South Korea's bioplasma technology firm Plasmapp said on Friday that it signed a memorandum of understanding with Curexo, a domestic medical robot m...
Jan 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion acquires approval to sell Vegzelma in Canada
South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima receives approval in 100 countries in 10 years
South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...
Jan 03, 2023 (Gmt+09:00)
-
Korean chipmakers
Applied Materials injects $40 mn in glass substrate maker Absolics
Applied Materials Inc., a global leading equipment and software supplier to semiconductor makers, has invested 51 billion won ($40.2 million) in Abs...
Jan 03, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom applies mobile edge computing tech in US
SK Telecom Co. said on Thursday it had transmitted terrestrial broadcasting in the US capital of Washington D.C. using mobile edge computing (MEC) a...
Dec 30, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotechs target US labs to speed up regulatory approval for tests
South Korean molecular diagnostics companies are increasingly buying high-quality laboratories in the US that meet federal regulatory standards in a...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Airlines
Chinese regulator approves Korean Air-Asiana merger
The merger between South Korea's two leading airlines Korean Air Lines Co. and Asiana Airlines Inc. passed a hurdle as China's antitrust watchdog ga...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Petrochemicals
Hyundai Heavy develops new chemical-resistant paint for PC carriers
Hyundai Heavy Industries Group said Wednesday that it has developed a paint product for petrochemical product (PC) carriers with significantly impro...
Dec 21, 2022 (Gmt+09:00)
-
Carbon neutrality
Samsung Heavy receives approval from US on gas recovery system
Samsung Heavy Industries, a major shipbuilder in South Korea, said on Tuesday that its boil-off gas recovery system (BReS) for LNG-powered vessels h...
Dec 20, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand